Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors-Reference-Cited by-同舟云学术

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors

Published:2016-12-23 Issue:6 Volume:1 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Gilman Morgan S. A.¹,Castellanos Carlos A.²,Chen Man³,Ngwuta Joan O.³,Goodwin Eileen²,Moin Syed M.³,Mas Vicente⁴,Melero José A.⁴,Wright Peter F.⁵,Graham Barney S.³,McLellan Jason S.¹,Walker Laura M.²

Affiliation:

1. Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.

2. Adimab LLC, Lebanon, NH 03766, USA.

3. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

4. Centro Nacional de Microbiología and CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

5. Department of Pediatrics, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.

Abstract

Anti–RSV F antibody repertoire profiling reveals new opportunities for vaccine design and passive therapy.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference62 articles.

1. Palivizumab for the prevention of respiratory syncytial virus infection;Rogovik A. L.;Can. Fam. Physician,2010

2. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

3. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group;Groothuis J. R.;Pediatrics,1995

4. Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

5. Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toolkit for mapping the clonal landscape of tumor-infiltrating B cells;Seminars in Immunology;2024-03

2. All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?;Vaccines;2024-01-18

3. Single B-cell sequencing in monoclonal antibody discovery;Comprehensive Precision Medicine;2024

4. Current state and challenges in respiratory syncytial virus drug discovery and development;Antiviral Research;2024-01

5. Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface;Journal of Virology;2023-12-21